SHANDORA HUNNICUTT: Open Payments
NPI 1487663480 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,138 in 57 payments from 22 companies in 2025. Trend: 2023 $934 · 2024 $1,341 · 2025 $1,138
Food & beverage: $1,070Education: $68
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $202 |
| Astellas Pharma US Inc | 7 | $174 |
| PFIZER INC. | 6 | $102 |
| Amgen Inc. | 5 | $83 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $62 |
| ABBVIE INC. | 3 | $61 |
| Otsuka America Pharmaceutical, Inc. | 2 | $54 |
| SHIELD THERAPEUTICS INC | 3 | $52 |
| Alexion Pharmaceuticals, Inc. | 2 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
Products named: Ozempic, Veozah, REXULTI, NURTEC ODT, Kerendia, Wegovy, ACCRUFER, OTEZLA.
Industry payments across GA — which companies pay providers there.
